期刊文献+

拓扑替康联合治疗复发和难治性神经母细胞瘤 被引量:3

Curative effects of topotecan combined with doxorubicin and vincristine on children with recurrent and refractory neuroblastoma
下载PDF
导出
摘要 目的 观察拓扑替康联合阿霉素、长春新碱治疗复发和难治性神经母细胞瘤的疗效。方法  19例患儿均诊断为复发和难治性神经母细胞瘤 ,用金喜素 (国产拓扑替康 )、阿霉素、长春新碱治疗 4~ 6个周期 ,进行疗效和不良反应评价。结果 完全缓解 1例 ,部分缓解 11例 ,稳定 3例 ,进展 4例 ,总有效率为 6 3%。不良反应主要为血液系统毒性和消化道反应 ,但患儿均能耐受 ,无相关性死亡。结论 拓扑替康联合阿霉素。
作者 苗战会 路平
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2004年第7期584-585,共2页 Journal of Applied Clinical Pediatrics
  • 相关文献

参考文献5

二级参考文献2

共引文献3

同被引文献23

  • 1金先庆.加强小儿实体肿瘤临床及临床基础研究[J].中华小儿外科杂志,2004,25(3):199-200. 被引量:1
  • 2戴朝霞,张阳,钟敏,孙婧华,李曼,张卓,冯仲珉,关小倩.TEP方案治疗小细胞肺癌21例临床分析[J].肿瘤防治杂志,2004,11(4):401-403. 被引量:1
  • 3Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy,autologous bone marrow transplantation, and 13 - cis- retinoic acid.Children's Cancer Group [J]. N Engl J Med, 1999,341: 11651173.
  • 4Tsuchida Y, Ikeda H, Shitara T, et al. Evaluation of the results of neuroblastoma screening at six months of age[J]. Med Pediatr Oncol, 2000,34: 80 - 81.
  • 5Kaneko M, Tsuchida Y, Mugishima H, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neroblastoma with MYCN amplification[J]. J Pediatr Hematol Oncol,2002,24:613-621.
  • 6Imaizumi M, Watanabe A, Kikuta A, et al. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation:a retrospective analysis from the Tohoku Neurobastoma Study Group [J]. Tohoku J Exp Med, 2001,195 (2) :73 - 83.
  • 7Stram DO, Matthay KK, Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies[J]. J Clin Oncol, 1996,14:2417 - 2426.
  • 8Villablanca JG, Khan AA, Avramis VI, et al. Phase I trail of 13-cis - retinoic acid in children with neuroblastoma following bone marrow transplantation[J]. J Clin Oncol, 1995,13: 894 - 901.
  • 9Shitara T, Shimata A, Tsuchida Y, et al. Successful clinical response to irinotecan in replased neuroblastoma[J]. Med Pediatr Oncol, 2003:126 - 128.
  • 10Kuroiwa M,Takeuchi T, Lee JH, et al. Continuous versus intermittent administration of human endostatin in xenografted human neuroblastoma[J]. J Pediatr Surg,2003,38:1499 - 1505.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部